Fig. 5.
Nalmefene prevention of salvinorin A-induced facial relaxation (top) and ptosis (bottom) (n = 5). Nalmefene (0.1 mg/kg s.c.) was administered as a 30-min pretreatment (PT) to salvinorin A (0.032 mg/kg). Other details as in Fig. 4.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.